tiprankstipranks
bioMerieux (FR:BIM)
PARIS:BIM

bioMerieux (BIM) Technical Analysis

3 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
bioMerieux’s (BIM) Moving Averages Convergence Divergence (MACD) indicator is -1.25, suggesting bioMerieux is a Sell.
bioMerieux’s (BIM) 20-Day exponential moving average is 96.26, while bioMerieux’s (BIM) share price is €95.95, making it a Buy.
bioMerieux’s (BIM) 50-Day exponential moving average is 98.09, while bioMerieux’s (BIM) share price is €95.95, making it a Sell.

bioMerieux (BIM) Pivot Points

Jun 02, 2024, 05:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
92.23
92.77
93.58
94.12
94.93
95.47
96.28
Fibonacci
92.77
93.28
93.60
94.12
94.63
94.95
95.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

bioMerieux (BIM) Moving Averages

Jun 02, 2024, 05:10 PM
Period
Simple
Exponential
MA5
94.91Buy
95.35Buy
MA10
94.89Buy
95.37Buy
MA20
96.29Buy
96.26Buy
MA50
98.98Sell
98.09Sell
MA100
100.12Sell
98.69Sell
MA200
97.34Sell
97.03Buy
bioMerieux’s (BIM) 10-Day exponential moving average is 95.37, while bioMerieux’s (BIM) share price is €95.95, making it a Buy.
bioMerieux’s (BIM) 100-Day exponential moving average is 98.69, while bioMerieux’s (BIM) share price is €95.95, making it a Sell.
bioMerieux’s (BIM) stock price is €95.95 and bioMerieux’s (BIM) 50-day simple moving average is 98.98, creating a Sell signal.
bioMerieux’s (BIM) stock price is €95.95 and bioMerieux’s (BIM) 100-day simple moving average is 100.12, creating a Sell signal.
bioMerieux’s (BIM) stock price is €95.95 and bioMerieux’s (BIM) 200-day simple moving average is 97.34, creating a Sell signal.

bioMerieux (BIM) Technical Indicators

Jun 02, 2024, 05:10 PM
Name
Value
Implied Action
RSI (14)
51.23
Neutral
STOCH (9,6)
63.89
Neutral
STOCHRSI (14)
48.87
Neutral
MACD (12,26)
-1.25
Sell
ADX (14)
20.42
Neutral
Williams %R
-6.14
Sell
CCI (14)
-14.89
Neutral
ATR (14)
2.09
-
Ultimate Oscillator
58.45
Neutral
ROC
0.15
Buy
bioMerieux’s (BIM) Relative Strength Index (RSI) is 51.23, creating a Neutral signal.
bioMerieux’s (BIM) Trend Strength Indicator (ADX) is 20.42, creating a Neutral signal.
bioMerieux’s (BIM) Commodity Channel Index (CCI) is -14.89, creating a Neutral signal.
bioMerieux’s (BIM) Price Rate of Change (ROC) is 0.15, creating a Buy signal.

FAQ

Is BIM a Buy, Hold, or Sell?
Based on BIM’s technical indicators, BIM is a Hold.
    What is BIM’s RSI (14)?
    BIM’s RSI (14) is 51.23, which suggests BIM is a Neutral.
      What is BIM’s MACD?
      BIM’s MACD is -1.25, which suggests BIM is a Sell.
        What is BIM’s 5-day moving average?
        BIM’s 5-day moving average is 94.91, which suggests BIM is a Buy.
          What is BIM’s 20-day moving average?
          BIM 20-day moving average is 96.29, which suggests BIM is a Buy.
            What is BIM’s 50-day moving average?
            BIM’s 50-day moving average is 98.98, which suggests BIM is a Sell.
              What is BIM’s 200-day moving average?
              BIM’s 200-day moving average is 97.34, which suggests BIM is a Sell.
                What is BIM’s Williams % R (14)?
                BIM’s Williams % R (14) is -6.14, which suggests BIM is a Sell.
                  What is BIM’s CCI (14)?
                  BIM’s CCI (14) is -14.89, which suggests BIM is a Neutral.
                    What is the share price of bioMerieux?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis